Form DRSLTR - Correspondence Related to Draft Registration Statement:
SEC Accession No. 0001558370-21-011921
Filing Date
2021-08-18
Accepted
2021-08-18 17:29:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRSLTR 63609
  Complete submission text file 0001558370-21-011921.txt   64485
Mailing Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603
Business Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603 (312) 253-9800
Enfusion, Inc. (Filer) CIK: 0001868912 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRSLTR
SIC: 7372 Services-Prepackaged Software